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Abstract
Background: Although the usefulness of susceptibility-weighted imaging (SWI) for detecting basal ganglia
germinoma has been reported, the technique is not widely used. We recently encountered an unusual case
of primary cerebellar germinoma, presenting with progressive ataxia and cranial nerve palsy, characterized by
gradually enlarging low-intensity lesions visible with both T2*-weighted imaging (T2*WI), which were the key
to the diagnosis.
Case presentation: A 30-year-old man was referred to our hospital because of slowly progressive dizziness
and mild ataxia. Magnetic resonance imaging (MRI) revealed a small, low-intensity spot in the left cerebellar
peduncle on the T2*WI and SWI without enhancement. Cerebral angiography revealed no vascular abnormality. The
serum α-fetoprotein value was normal. A steroid-pulse was administered as a therapeutic and diagnostic trial, but the
symptoms improved little. The patient was discharged from the hospital but soon developed brainstem dysfunction,
characterized by dyspnea or hiccups, and he was readmitted. T2*WI imaging revealed expanded and extended
spotty lesions in the cerebellum and brainstem, which had not enhanced with contrast agent previously. Targeted
stereotactic biopsy of the newly enhanced cerebellar lesion was performed; histopathological examination of the tissue
revealed pure germinoma. Serum and cerebral spinal fluid values of beta-human chorionic gonadotropin were
not significantly elevated. Chemotherapy with carboplatin and etoposide was initiated. The enhanced lesion
disappeared promptly, but the patient continued to require assisted automatic ventilation because of paralysis
of respiratory muscles.
Conclusions: We conclude that enlarging low-intensity lesions on T2*WI and SWI may be a reliable clue to
the diagnosis of germinomas, irrespective of their location, even without enhancement. Biopsy of the tumor
at an early stage is the only way to make the diagnosis conclusively and enable prompt start of treatment.
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Background
Intracranial germ cell tumors (GCT) are rare, compris-
ing only 0.6–2.8 % of all intracranial tumors [1–3].
About 40 % of GCTs are germinomas [4]. They may
arise from basal ganglia, cerebellum, and brainstem.
Radiographically, these tumors typically show isointense
signals by T1 or T2-weighted MRI but are revealed as
homogeneously enhanced lesions after contrast adminis-
tration. Therefore, without enhancement by a contrast
agent, GCTs are quite difficult to diagnose when present
in atypical locations. Here, we report a rare case of cere-
bellar germinoma presenting with progressive ataxia and
cranial nerve palsy, characterized by gradually enlarging
multiple low-intensity lesions visible with both T2*-
weighted imaging (T2*WI) and susceptibility weighted
imaging (SWI).
Case presentation
A 30-year-old male was referred to our hospital because
of symptoms of slowly progressive dizziness and mild
ataxia. He had been in good health until three years earlier
except for the past medical history of hepatitis B, when he
presented with transient dizziness without any abnormal
findings on MRI (see Additional file 1: Figure S1). Two
years previously, he began experiencing double vision,
ptosis of the right eyelid, and left upper limb ataxia, which
gradually worsened. He was first admitted to the depart-
ment of neurology in our hospital because degenerative
neurological disorder or other autoimmune diseases were
suspected. Hematological examinations were normal.
Conventional MRI revealed no specific findings, with the
exception of three small low-intensity spots located in the
left cerebellum on T2*-weighted image (T2*WI) and
susceptibility-weighted image (SWI) that were not en-
hanced by gadolinium (Fig. 1a, b, c). Cerebral angiography
showed no vascular abnormality. Because of his history of
chronic hepatitis B, the serum α-fetoprotein had been
measured several times, with negative results. Cerebro-
spinal fluid examinations were normal, except for an oli-
goclonal band. Autoimmune diseases or degenerative
Fig. 1 a SWI on the first admission revealed low-signal intensity spotty lesions in the left cerebellar peduncle (arrow). b T2*WI on the first admission.
Findings similar to those in Fig. 1a are present (arrow). c Contrast-enhanced MRI on the first admission showed no apparently enhanced
lesions, including in the cerebellar peduncle. d SWI obtained three months after the first admission revealed de novo low-intensity spots
in the medulla oblongata. e T2*WI obtained three months after the first admission. Findings are to those in Fig. 1d. f Contrast-enhanced
MRI obtained three months after the first admission showed no apparently enhanced lesions. g SWI obtained one year after the first admission
revealed spreading hypointensity- lesions adjacent to the fourth ventricle (arrows). h T2*WI obtained one year after the first admission. Findings similar
to those in Fig. 1g are present. i Contrast-enhanced MRI obtained one year after the first admission showed a slightly enhanced lesion around the
fourth ventricle. j SWI on the second admission revealed expanding lesions of the pons and right cerebellar peduncle (arrows). k T2*WI on the second
admission revealed findings similar to those in Fig. 1k. l Contract-enhanced MRI on the second admission showed an expanded enhanced lesion
around the fourth ventricle
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neurological disorders were suspected, but despite the ini-
tiation of steroid pulse therapy, the patient’s symptoms
remained unchanged. Three months later, follow-up MRI
studies revealed enlarged low-intensity lesions in the cere-
bellum and newly visible lesions in the brainstem with
T2*WI and SWI (Fig. 1d, e, f ). Nine months later, low in-
tensity lesions were observed in the right cerebellar hemi-
sphere, vermis, and dorsal surface of the brainstem with
T2*WI and SWI (Fig. 1g, h, i). At this time, newly en-
hanced lesions surrounding the fourth ventricle were
identified. However, a biopsy was not performed because
the lesions were deeply seated and the patient’s clinical
symptoms were stable.
Two months later, the patient was re-admitted with
persistent hiccups, gait disturbance, and dysphagia. He
became dyspneic and was intubated and ventilated.
Alpha-fetoprotein and human chorionic gonadotropin β-
subunit values were normal in serum and cerebral spinal
fluid. MRI studies revealed mildly enhanced lesions
surrounding the 4th ventricle and the left cerebellar
hemisphere. With the use of T2*WI and SWI, low-
intensity lesions were observed to be increased and ex-
panded in bilateral cerebella and the dorsal brainstem.
(Fig. 1j, k, l). A stereotactic biopsy was performed, tar-
geting the newly enhanced lesion in the left cerebellum;
histopathological examination revealed large and round
neoplastic cells with lymphocytic infiltration suggestive
of a two-cell pattern (Fig. 2a, b). The tumor cells tested
immunopositive for c-Kit (Fig. 2c), SALL4 (Fig. 2d),
and PLAP (Fig. 2e), characteristic of germinoma. Ki-67
labeling index was high (Fig. 2f ). Soon after the patho-
logical diagnosis was made, the patient underwent three
cycles of chemotherapy with carboplatin (450 mg/m2,
day1) and etoposide (150 mg/m2, day1-3). The en-
hanced lesions disappeared promptly, but low-intensity
lesions remained visible by T2*WI and SWI. Radiation
therapy was difficult to perform because of the pa-
tient’s poor physical condition. With rehabilitation, he
made slight progress, and he now lives in his own
house, but he remains almost bedridden and requires
Fig. 2 Histological findings of the tumor a and b; h-e stain of the tumor. The tumor is composed of sheets and lobules of large and pale cells
with often indistinct cell membranes and somewhat vacuolated cytoplasm. Locally, lymphocytic infiltration is present. c-f Immunohistochemically,
tumor cells are positive for c-Kit (c) and strongly positive for SALL4 (d). Also, tumor cells are weakly positive for PLAP (e). The Ki-67 labeling index
is high in the tumor cells (f). (Original magnification; A × 200, B-F × 400)
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tracheostomy and ventilator assist because of the damage
of the brainstem and cerebellum.
Discussion
Germinomas typically arise in regions adjacent to the
third ventricle, such as the pineal body and neurohyp-
ophysis, but they may be present also in the basal ganglia.
Germinomas originating in the cerebellum are quite rare
[5–11] (see Additional file 2: Table S1); in one study, only
three of 153 intracranial GCTs were located in the cere-
bellum [12]. It is not difficult to diagnose intracranial
GCTs when they have a typical location and radiographic
features. However, an intracranial GCT located in the
basal ganglia often is difficult to detect because enhance-
ment is usually slight or absent [2]. Recent reports have
emphasized the effectiveness of SWI in early detection of
basal ganglia GCTs [13]. SWI can be used to detect blood
products and accumulation of biologic metal, thereby
providing additional information in evaluation of brain
tumors. SWI may be useful also in the detection of intra-
cranial GCTs, because this type of tumor is characterized
by a high incidence of intra-tumor micro bleeds. Since
T2*WI is also extremely sensitive for detecting micro
bleeds in the brain, both techniques are considered useful
for early detection of intracranial GCTs [14].
In the present case, low-intensity spots were present
in the left cerebellar hemisphere with both T2*WI and
SWI at early stages of tumor growth, when the tumor
showed no enhancement after gadolinium administra-
tion. To our knowledge, this is the first report describing
low-signal intensity lesions on T2*WI without any en-
hancement. Interestingly, low-signal lesions on T2*WI
and SWI were found to concomitantly expand with tumor
progression. Although having not been performed in our
case, 11C-methionine positron emission topography pro-
vides valuable information for making the diagnosis of
germinoma, and it is useful also for evaluating treatment
effects and monitoring for tumor recurrence [4, 15].
Since intracranial GCTs are extremely sensitive to ra-
diation, the possibility remains that our patient’s tumor
became temporarily invisible by conventional MRI
techniques due to the radiation exposure of the CT
scan. Since diagnostic CT scans are required in clinical
practice, the patient had received a CT scan prior to
the initiation of the MRI studies. Although conven-
tional MRI showed no unremarkable findings, low-
signal lesions were observed with T2*WI and SWI,
suggesting that low-signal lesions may not be affected
by radiation and may be useful in detecting intracranial
GCTs after radiation exposure associated with CT. This
view is supported by the fact that the low-intensity
lesions remained visible after chemotherapy, while
gadolinium-enhanced regions disappeared.
The symptoms of intracranial GCTs depend on tumor
location, and typical symptoms include hydrocephalus,
diabetes insipidus, hypopituitarism, hemiparesis, or
higher cognitive dysfunction [16]. Intracranial GCTs lo-
cated near the fourth ventricle are also known to present
with trigeminal, abducens, and facial nerve paresis and
cerebellar signs [17]. In the present case, the patient pre-
sented with slowly progressive ataxia, followed by cranial
nerve palsy and brainstem dysfunction, such as difficulty
breathing. In such situations, patients are more likely to
be consulted by neurologists or general physicians, be-
cause neurodegenerative diseases, infectious diseases, or
autoimmune diseases are considered to be more likely.
Therefore, not only neurosurgeons but neurologists,
neuroradiologists, and general physicians should know
that CNS germinomas could have the radiographic find-
ings and symptoms described above. Although measur-
ing the serum alpha-fetoprotein and human chorionic
gonadtropin is important, they are often negative in pure
germinomas, as in our case. The only test that conclu-
sively makes the diagnosis is biopsy, and it should be
performed without hesitation if the symptoms are pro-
gressive and if there are any abnormal lesions on MRI.
Our study suggests that hypointensity changes in T2*WI
and SWI are helpful for making the early diagnosis of
intracranial GCTs arising in atypical locations.
Conclusions
Enlarging, low-intensity lesions on T2*WI and SWI may
be a reliable clue to the diagnosis of germinomas, irre-
spective of their location. Biopsy at the early stage is the
only way to conclusively make the diagnosis and lead to
early treatment.
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